6 completed. 6 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Peritonitis: new trials by email Literature Review of Peritonitis trials Research Report on Peritonitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis Meropenem 1000 mg, Aztreonam 2000 mg, automated peritoneal dialysis with following long time dwell - Peritoneal Dialysis Associated Peritonitis, Peritoneal Dialysis (PD) | Phase 2 / Phase 3 | Completed | Karl Landsteiner Insitute for Nephrology and Haemato-Oncology | 12 | 2021-08-31 | 2025-08-11 |
| The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis Cholecalciferol (2000iu qd), Routine therapy for PD - Peritoneal Dialysis-associated Peritonitis, Vitamin D Deficiency | Phase 2 | Completed | Peking University First Hospital | 60 | 2017-09-30 | 2021-08-18 |
| Comparative Evaluation of Intra-operative Peritoneal Lavage With Super Oxidized Solution and Normal Saline in Peritonitis Cases Super Oxidized Solution in group I - Peritonitis | Phase 2 | Completed | Maharishi Markendeswar University (Deemed to be University) | 290 | 2014-12-01 | 2016-08-30 |
| Protective Effect of N-acetylcysteine Against From Ototoxicity N-acetylcysteine - Hearing Loss, Extreme | Phase 2 / Phase 3 | Completed | TC Erciyes University | 60 | 2010-06-01 | 2011-11-16 |
| Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels rhu-pGelsolin, Placebo - Low Gelsolin, Trauma | Phase 1 / Phase 2 | Completed | Critical Biologics Corporation | 40 | 2008-03-01 | 2010-09-29 |
| Prevention of Drug Induced Ototoxicity in Peritoneal Dialysis Patients by N-Acetylcysteine N-acetylcysteine - Drug-induced Ototoxicity in Peritoneal Dialysis Patients | Phase 2 | Completed | TC Erciyes University | 60 | 2008-02-01 | 2010-05-27 |
Infections (2) · Ototoxicity (2) · Burns (1) · Deafness (1) · Kidney Failure, Chronic (1) · Meretoja syndrome (1) · Pneumonia (1) · Sepsis (1) · Systemic Inflammatory Response Syndrome (1) · Vitamin D Deficiency (1) · Wounds and Injuries (1)
Digestive System Diseases (6) · Intraabdominal Infections (6) · Peritoneal Diseases (6) · Infections (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Chemically-Induced Disorders (2) · Drug-Related Side Effects and Adverse Reactions (2) · Ear Diseases (2) · Otorhinolaryngologic Diseases (2) · Radiation Injuries (2) · Wounds and Injuries (2) · Avitaminosis (1) · Chronic Disease (1) · Deficiency Diseases (1)
Acetylcysteine (2) · Aztreonam (1) · Cholecalciferol (1) · Meropenem (1) · Saline Solution (1)
TC Erciyes University (2) · Critical Biologics Corporation (1) · Karl Landsteiner Insitute for Nephrology and Haemato-Oncology (1) · Maharishi Markendeswar University (Deemed to be University) (1) · Peking University First Hospital (1)
Turkey (Türkiye) (2) · Austria (1) · China (1) · Hong Kong (1)
Bulent Tokgoz, MD (1) · Ismail Kocyigit, MD (1) · Jie Dong (1) · Martin F Wiesholzer, MD (1) · Richard C Straube, MD (1) · Selene Tam, PhD (1) · Wai M Chan, MBBS (1)